James Levine - 07 Mar 2024 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRDF	Stock Options	Award	$0	+205,008	+27%	$0.000000	962,496	07 Mar 2024	Common Stock	205,008	$3.51	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	25% of the shares subject to the option will vest on March 7, 2025 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the continued service of the reporting person.